Categories: aggregated

New THC-CBD Pill for MS and Huntington’s Disease May Be First to Benefit from Biden’s New Marijuana Research Bill

In related news, President Biden signed the Marijuana Research and Expansion Act into law. This will speed up researchers’ bids for DEA schedule 1 registration authorization to undertake these trials. After seven hard years of waiting, the MMJ group of firms can finish their mission of performing clinical studies on Huntington’s Disease and Multiple Sclerosis. MMJ has received FDA Orphan Designation for its Huntington’s disease clinical trials.

Jason

Share
Published by
Jason

Recent Posts

Scotts Miracle Gro Taps Out of the Cannabis Market – Dumps Cannabis Division for an Interest Bearing Promissory Note

The transfer of The Hawthorne Collective to a strategic partner was made in exchange for…

17 hours ago

A Guide To Different Vape Carts In The Market: Which One Is Right For You?

A vape cartridge is essentially the most important feature of any vape pen. The cart…

2 days ago

Marijuana Myth Buster : We Need More Research – The Fallback Excuse Not Backed by Facts

But here's what keeps me up at night: How much research is enough? We currently…

3 days ago

The Cannabis Shell Game – How Inversion Threatens the Legal Weed Market and Your Stash

As someone who's watched the cannabis industry evolve from underground operations to licensed businesses with…

3 days ago

Is There Any Weed in the Minecraft Movie? – Is There Cannabis Easter Egg in the Film?

The question about marijuana in the Minecraft movie might seem out of place, given the…

4 days ago

Celebrate 420 weekend with cannabis, community, and creativity at MARY FEST NYC

Get ready for MARY FEST! New York’s premier cannabis & culture festival kicks off April…

5 days ago